Deschler Sebastian, Pohl-Topcu Junika, Ramsauer Lukas, Meiser Philippa, Erlacher Sophia, Schenk Robin P, Maurer H Carlo, Shen Peng, Kager Juliane, Zink Joseph, Pistrenko Karyna, Monte Enric Redondo, Weber Julius, Wasmaier Lena, Laschinger Melanie, Hüser Norbert, Geisler Fabian, Thorburn Douglas, Nieß Hanno, Wiedemann Gabriela M, Zischka Hans, Heikenwälder Mathias, Kleigrewe Karin, Mogler Carolin, Böttcher Jan P, Knolle Percy A, Schmid Roland M, Böttcher Katrin
TUM School of Medicine and Health, Department of Clinical Medicine - Clinical Department for Internal Medicine II, University Medical Centre, Technical University of Munich, Germany.
Department of Experimental Immunology, Institute of Immunology, University of Tübingen, Tübingen, Germany; M3 Research Center, University Hospital Tübingen, University of Tübingen, Tübingen, Germany; Institute of Molecular Immunology, TUM University Hospital, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
J Hepatol. 2025 Jun 19. doi: 10.1016/j.jhep.2025.06.006.
BACKGROUND & AIMS: Mucosal-associated invariant T (MAIT) cells constitute a highly abundant innate-like T cell population in the human liver that is critical for immune surveillance of hepatic cancers but often dysfunctional in human hepatocellular carcinoma (HCC) for unclear reasons. Here, we sought to determine mechanisms that drive MAIT cells dysfunction in metabolic dysfunction-associated steatotic liver disease (MASLD), a chronic liver disease predisposing patients for HCC development.
We studied MAIT cell functionality, metabolism and anti-cancer activity directly ex vivo in patients with MASLD, as well as in co-culture models mimicking MASLD. (Single-cell) RNA sequencing was used for translation into clinical cohorts of patients with MASLD and MASLD-associated HCC.
We show that MAIT cells have lost their effector functions in patients with MASLD. We uncover that MAIT cell dysfunction is caused by MASLD-associated polyunsaturated fatty acids (PUFAs), which selectively accumulate in MAIT cells but not conventional CD8+ T cells or NK cells. Mechanistically, PUFAs drive MAIT cell dysfunction through intracellular formation of lipid peroxides that promote a state of 'metabolic exhaustion' characterised by compromised mitochondrial respiration and glycolysis in MAIT cells. Excessive signalling through this MASLD-PUFA-lipid peroxide axis results in MAIT cell death by ferroptosis. Interference with PUFA-induced lipid peroxide formation in MAIT cells reversed their metabolic exhaustion and prevented ferroptotic MAIT cell death, thereby restoring MAIT cell effector function and anti-cancer activity. In patients with HCC, high enrichment of the MAIT cell-PUFA gene signature linked to MAIT cell dysfunction was associated with poor survival.
Our findings uncover a novel immunometabolic axis that serves as a functional barrier for MAIT cell-mediated anti-cancer immunity and could be exploited for enhancement of immunotherapy. IMPACT AND IMPLICATIONS: ; This study identifies a novel immunometabolic axis by which polyunsaturated fatty acids (PUFAs) accumulating in MASLD liver tissue drive MAIT cell dysfunction through lipid peroxide-induced metabolic exhaustion and ferroptosis, thereby impairing their anti-tumour activity. These findings reveal how MASLD creates an immune-permissive environment that may facilitate HCC development and -progression. Targeting the PUFA-lipid peroxide axis could restore MAIT cell function and enhance current immunotherapeutic anti-cancer strategies.
黏膜相关恒定T(MAIT)细胞是人类肝脏中高度丰富的固有样T细胞群体,对肝癌的免疫监视至关重要,但在人类肝细胞癌(HCC)中常功能失调,原因不明。在此,我们试图确定在代谢功能障碍相关脂肪性肝病(MASLD,一种使患者易患HCC的慢性肝病)中驱动MAIT细胞功能失调的机制。
我们直接在体外研究了MASLD患者以及模拟MASLD的共培养模型中MAIT细胞的功能、代谢和抗癌活性。(单细胞)RNA测序用于转化为MASLD和MASLD相关HCC患者的临床队列研究。
我们发现MAIT细胞在MASLD患者中丧失了效应功能。我们发现MAIT细胞功能失调是由MASLD相关的多不饱和脂肪酸(PUFA)引起的,这些PUFA选择性地在MAIT细胞中积累,而不在传统CD8 + T细胞或NK细胞中积累。从机制上讲,PUFA通过细胞内脂质过氧化物的形成驱动MAIT细胞功能失调,脂质过氧化物促进了一种“代谢耗竭”状态,其特征是MAIT细胞中线粒体呼吸和糖酵解受损。通过这个MASLD-PUFA-脂质过氧化物轴的过度信号传导导致MAIT细胞因铁死亡而死亡。干扰MAIT细胞中PUFA诱导的脂质过氧化物形成可逆转其代谢耗竭并防止铁死亡性MAIT细胞死亡,从而恢复MAIT细胞的效应功能和抗癌活性。在HCC患者中,与MAIT细胞功能失调相关的MAIT细胞-PUFA基因特征的高度富集与较差的生存率相关。
我们的研究结果揭示了一种新的免疫代谢轴,它是MAIT细胞介导的抗癌免疫的功能障碍,可用于增强免疫治疗。影响与意义:本研究确定了一种新的免疫代谢轴,通过该轴,MASLD肝组织中积累的多不饱和脂肪酸(PUFA)通过脂质过氧化物诱导的代谢耗竭和铁死亡驱动MAIT细胞功能失调,从而损害其抗肿瘤活性。这些发现揭示了MASLD如何创造一个免疫许可环境,可能促进HCC的发生和发展。靶向PUFA-脂质过氧化物轴可以恢复MAIT细胞功能并增强当前的免疫治疗抗癌策略。